<DOC>
	<DOCNO>NCT02748226</DOCNO>
	<brief_summary>1 . Study design : multicenter retrospective prospective observational study 2 . Study Cohort : 1 . Retrospective cohort : This cohort retrospectively enroll patient low extremity artery disease underwent endovascular treatment January 2006 date approval IRB participate hospital . Informed consent waive IRB . 2 . Prospective cohort : This cohort prospectively enroll patient low extremity artery disease undergo endovascular treatment date approval IRB July , 2018 participate hospital . Informed consent obtain prior enrollment . 3 . Baseline clinical lesion characteristic , procedural post-procedural data , clinical outcome , hemodynamic , image follow-up data investigate . Primary patency target lesion revascularization rate total cohort patient subgroup evaluate . Risk factor restenosis target lesion revascularization determine .</brief_summary>
	<brief_title>Korean Vascular Intervention Society Multicenter Registry Study Outcomes Endovascular Therapy Lower Limb Artery Diseases : ( A Retrospective &amp; Prospective Observational Study )</brief_title>
	<detailed_description>This observational study . The study include patient underwent endovascular treatment low extremity artery diseases investigates immediate late outcome treatment . The investigator assign specific intervention .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Retrospective data 1 . Age 20 year old 2 . Patients treatment try symptomatic peripheral artery disease January 2006 IRB approval date Prospective data 1 . Age 20 year old 2 . Patients treatment try symptomatic peripheral artery disease IRB approval date 3 . Symptomatic peripheral artery disease : Moderate severe claudication ( Rutherford category 1 3 ) Critical limb ischemia ( Rutherford category 4 6 ) Pregnant woman woman potential childbearing Moderate Alzheimer 's disease , mental illness neurological disease understand purpose clinical trial Methods Life expectancy &lt; 1 year due comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>